GB0207286D0 - Salt - Google Patents

Salt

Info

Publication number
GB0207286D0
GB0207286D0 GBGB0207286.6A GB0207286A GB0207286D0 GB 0207286 D0 GB0207286 D0 GB 0207286D0 GB 0207286 A GB0207286 A GB 0207286A GB 0207286 D0 GB0207286 D0 GB 0207286D0
Authority
GB
United Kingdom
Prior art keywords
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0207286.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drug Discovery Laboratory AS
Original Assignee
Drug Discovery Laboratory AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Discovery Laboratory AS filed Critical Drug Discovery Laboratory AS
Priority to GBGB0207286.6A priority Critical patent/GB0207286D0/en
Publication of GB0207286D0 publication Critical patent/GB0207286D0/en
Priority to EP03710019A priority patent/EP1487445A1/en
Priority to PCT/GB2003/001329 priority patent/WO2003082281A1/en
Priority to AU2003214447A priority patent/AU2003214447A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0207286.6A 2002-03-27 2002-03-27 Salt Ceased GB0207286D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0207286.6A GB0207286D0 (en) 2002-03-27 2002-03-27 Salt
EP03710019A EP1487445A1 (en) 2002-03-27 2003-03-27 Obidoxime dimesylate
PCT/GB2003/001329 WO2003082281A1 (en) 2002-03-27 2003-03-27 Obidoxime dimesylate
AU2003214447A AU2003214447A1 (en) 2002-03-27 2003-03-27 Obidoxime dimesylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207286.6A GB0207286D0 (en) 2002-03-27 2002-03-27 Salt

Publications (1)

Publication Number Publication Date
GB0207286D0 true GB0207286D0 (en) 2002-05-08

Family

ID=9933860

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0207286.6A Ceased GB0207286D0 (en) 2002-03-27 2002-03-27 Salt

Country Status (4)

Country Link
EP (1) EP1487445A1 (en)
AU (1) AU2003214447A1 (en)
GB (1) GB0207286D0 (en)
WO (1) WO2003082281A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130438A (en) * 1985-11-20 1992-07-14 The United States Of America As Represented By The Secretary Of The Army Bis-methylene ether pyridinium compound preparation

Also Published As

Publication number Publication date
WO2003082281A1 (en) 2003-10-09
AU2003214447A1 (en) 2003-10-13
EP1487445A1 (en) 2004-12-22

Similar Documents

Publication Publication Date Title
HUS1900052I1 (en) 2-acylaminothiazole derivative or salt thereof
IL166239A0 (en) 2-cyano-4-fluoropyrrolidine derivative or its salt
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
EP1466407A4 (en) Modulator- amplifier
GB2392460B (en) Delayed-gelation solution
AP2004003119A0 (en) Substituted hydroxyethylamines
AU2003252028A8 (en) Heterodiamondoids
IL166740A0 (en) Substituted heterocyclylpyrimidines
AU2003279495A8 (en) Alert-modeling
PT1487778E (en) Substituted 4-aminocyclohexanols
PL373794A1 (en) New salts
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003264900A8 (en) Cast-cutter
AU2003262681A8 (en) Hemo-aide
GB0204568D0 (en) Pastebrush
PL377325A1 (en) Substituted benzodioxepins
AU2002341221A8 (en) Honey-brandy
AU2003253735A8 (en) Vacuolins
GB0207286D0 (en) Salt
GB0206255D0 (en) Novel salt forms
AU2003244272A8 (en) Segment
GB0311011D0 (en) U-seam
AU2326P (en) Gavol Gazania rigens
AU2327P (en) Archnah Arctotis fastuosa

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)